Association of gene polymorphisms with chronic kidney disease in Japanese individuals

International Journal of Molecular Medicine

Volumn 24, Issue 4, 2009, Pages 539-547

  Yoshida, Tetsuro ^a   Kato, Kimihiko ^b   Yokoi, Kiyoshi ^b   Oguri, Mitsutoshi ^c   Watanabe, Sachiro ^d   Metoki, Norifumi ^e   Yoshida, Hidemi ^f   Satoh, Kei ^f   Aoyagi, Yukitoshi ^g   Nozawa, Yoshinori ^h   Yamada, Yoshiji ⁱ  

^a Inabe General Hospital   (Japan)

^b GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^e Hirosaki Stroke Center   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^h TOKAI GAKUEN UNIVERSITY   (Japan)

ⁱ MIE UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; End stage renal disease; Genetics; Polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 10; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 12; CYSTEINE; GENE PRODUCT; JUNCTOPHILIN 3; METALLOPROTEINASE; MYOSIN; MYOSIN VIIB; PITRILYSIN METALLOPEPTIDASE 1; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 2; SERINE PROTEINASE; THREONINE; UNCLASSIFIED DRUG;

AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

A KINASE ANCHOR PROTEINS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CELL CYCLE PROTEINS; CHRONIC DISEASE; FEMALE; FURIN; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KIDNEY DISEASES; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; MYOSINS; POLYMORPHISM, GENETIC;

EID: 70350761419     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000263     Document Type: Article

References (39)

1. Imai E, Matsuo S, Makino H, et al: Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res 31: 1101-1107, 2008.
2. Weiner DE, Tighiouart H, Amin MG, et al: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004.
3. Jafar TH, Stark PC, Schmid CH, et al: Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 139: 244-252, 2003.
4. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002.
5. Gharavi AG, Yan Y, Scolari F, et al: IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet 26: 354-357, 2000.
6. Hanson RL, Craig DW and Millis MP: Identification of PVT1 as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study. Diabetes 56: 975-983, 2007.
7. Yoshida T, Kato K, Fujimaki T, et al: Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome. Genomics 93: 221-226, 2009.
8. Yoshida T, Kato K, Yokoi K, et al: Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus. Int J Mol Med 23: 529-537, 2009.
9. Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S and Tokunaga K: Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol 17: 823-830, 2006.
10. Wetmore JB, Hung AM, Lovett DH, Sen S, Quershy O and Johansen KL: Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int 68: 278-284, 2005.
11. Matsuo S, Imai E, Horio M, et al: Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.
12. Go AS, Chertow GM, Fan D, McCulloch CE and Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
13. Imai E, Horio M, Yamagata K, et al: Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 31: 433-441, 2008.
14. Yamada Y, Fuku N, Tanaka M, et al: Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study. Atherosclerosis (published online).
15. Ishizaka N, Ishizaka Y, Toda E, et al: Association between chronic kidney disease and carotid intima-media thickening in individuals with hypertension and impaired glucose metabolism. Hypertens Res 30: 1035-1041, 2007.
16. Yoshida T, Kato K, Fujimaki T, et al: Association of genetic variants with chronic kidney disease in Japanese individuals. Clin J Am Soc Nephrol 4: 883-890, 2009.
17. Yoshida T, Kato K, Yokoi K, et al: Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension. Hypertens Res 32: 411-418, 2009.
18. Yoshida T, Kato K, Yokoi K, et al: Association of gene polymorphisms with chronic kidney disease in high- or low-risk subjects defined by conventional risk factors. Int J Mol Med 23: 785-792, 2009.
19. Yoshida T, Kato K, Yokoi K, et al: Association of genetic variants with chronic kidney disease in individuals with different lipid profiles. Int J Mol Med 24: 233-246, 2009.
20. Itoh Y, Mizuki N, Shimada T, et al: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57: 717-729, 2005.
21. Benjamini Y and Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B 57: 289-300, 1995.
22. Cooper DN, Millar DS, Wacey A, Pemberton S and Tuddenham EG: Inherited factor X deficiency: molecular genetics and pathophysiology. Thromb Haemost 78: 161-172, 1997.
23. Millar DS, Elliston L, Deex P, et al: Molecular analysis of the genotype-phenotype relationship in factor X deficiency. Hum Genet 106: 249-257, 2000.
24. Di Scipio RG, Hermodson MA, Yates SG, et al: A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 16: 698-706, 1977.
25. Graves CB, Munns TW, Willingham AK, et al: Rat factor X is synthesized as a single chain precursor inducible by prothrombin fragments. J Biol Chem 257: 13108-13113, 1982.
26. Mann KG, Nesheim ME, Church WR, Haley P and Krishnaswamy S: Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76: 1-16, 1990.
27. Leytus SP, Foster DC, Kurachi K and Davie EW: Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. Biochemistry 25: 5098-5102, 1986.
28. Hung HL and High KA: Liver-enriched transcription factor HNF-4 and ubiquitous factor NF-Y are critical for expression of blood coagulation factor X. J Biol Chem 26: 2323-2331, 1996.
29. Schüttrumpf J, Jimenez-Boj E, Graf S, Huber K and Watzke HH: A genetic variant in the promoter of coagulation factor X increases the risk of acute coronary syndromes. Thromb Haemost (Suppl S): 509, 1999.
30. De Visser MC, Poort SR, Vos HL, Rosendaal FR and Bertina RM: Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis. Thromb Haemost 85: 1011-1017, 2001.
31. Yoshida H, Ohagi S, Sanke T, Furuta H, Furuta M and Nanjo K: Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. Diabetes 44: 389-393, 1995.
32. Weil D, Levy G, Sahly I, et al: Human myosin VIIA responsible for the Usher 1B syndrome: a predicted membrane-associated motor protein expressed in developing sensory epithelia. Proc Natl Acad Sci USA 93: 3232-3237, 1996.
33. Chen ZY, Hasson T, Zhang DS, et al: Myosin-VIIb, a novel unconventional myosin, is a constituent of microvilli in transporting epithelia. Genomics 72: 285-296, 2001.
34. Gordon T, Grove B, Loftus JC, et al: Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera. J Clin Invest 90: 992-999, 1992.
35. Lee SW, Kim WJ, Choi YK, et al: SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med 9: 900-906, 2003.
36. Falkevall A, Alikhani N, Bhushan S, et al: Degradation of the amyloid beta-protein by the novel mitochondrial peptidasome, PreP. J Biol Chem 281: 29096-29104, 2006.
37. Takeshima H, Komazaki S, Nishi M, et al: Junctophilins: a novel family of junctional membrane complex proteins. Mol Cell 6: 11-22, 2000.
38. Holmes SE, O'Hearn E, Rosenblatt A, et al: A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet 29: 377-378, 2001.
39. Orth SR: Smoking and the kidney. J Am Soc Nephrol 13: 1663-1672, 2002.